FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely, to a method for quantifying fluoroquinolone derivatives. Method for quantifying fluoroquinolone derivatives includes dissolving a sample of norfloxacin, pefloxacin mesylate, ofloxacin, lomefloxacin hydrochloride, ciprofloxacin hydrochloride, moxifloxacin, enoxacin, or sparfloxacin in a NaOH solution, then adding a double excess to the aliquot of substances, relative to the determined component of a p-anisidine solution in a mixture of ethanol and concentrated hydrochloric acid, holding the reaction mixture until yellow staining and subjecting the resulting solution to photocolorimetry relative to the comparison solution - solution of p-anisidine in the mixture of ethanol and concentrated hydrochloric acid, in certain conditions.
EFFECT: above method allows high accuracy in determining the amount of fluoroquinolones.
1 cl, 8 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
OPHTHALMIC OINTMENT FORMULATION AND METHOD FOR PREPARING SAME | 2012 |
|
RU2531937C2 |
MEDICINAL AGENT FOR TREATMENT OF SUPPURATIVE-INFLAMMATORY SKIN AND SOFT TISSUE DISEASES OF DIFFERENT AETIOLOGY | 2006 |
|
RU2326667C1 |
LOCAL ANTIMICROBIAL AGENT | 2007 |
|
RU2336877C1 |
PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2435583C1 |
FLUOROQUINOLONES BASED ON 4-DEOXYPYRIDOXINE | 2016 |
|
RU2634122C1 |
AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS | 2006 |
|
RU2428986C2 |
COMPLEX ANTIBACTERIAL AGENT FOR ANIMALS | 2014 |
|
RU2554797C1 |
COMPOSITION FOR PREVENTING OR TREATING PROCTOLOGICAL DISEASES | 2022 |
|
RU2814279C2 |
METHOD OF QUANTITATIVE DETERMINATION OF MORPHOLINE DERIVATIVES | 2020 |
|
RU2740909C1 |
Authors
Dates
2022-07-29—Published
2021-05-31—Filed